Sun pharmaceutical News: Sun pharmaceutical Latest News, Sun pharmaceutical Today news, Sun pharmaceutical Breaking News

Sun Pharma Q1 profit rises 27%; India formulations grow 16%

Sun Pharma Q1 profit rose 27% YoY as India formulations grew 16%; see key revenue, EBITDA and market share details.

Updated: July 31, 2026 15:16 IST

Stocks making the biggest moves today including Infosys, Swiggy and IndiGo

Trump’s pharma tariff proposals: Which stocks face the biggest risk? Macquarie spots the winners and losers

Infosys, Swiggy, IndiGo, Cipla, Coforge, Mphasis and Meesho led the midday action as earnings, guidance revisions and company-specific announcements drove…

July 24, 2026 13:12 IST

A financial trading terminal displaying the Nifty Pharma Index drop alongside a visual timeline breakdown of Donald Trump's phased tariff policy on generic drug imports—showing 0% duty until August 2028, 100% in 2028–2029, and 200% from August 2029 onward.

Pharma stocks fall after Trump’s 200% tariff announcement for generic imports: Experts decode what it means

Track pharma stocks as Trump’s phased US tariff plan hits sentiment, though analysts say India’s cost edge may cushion generic…

July 22, 2026 10:36 IST

Sun Pharma turns ex-dividend on July 7 – Check eligibility, final payout, other key details

Sun Pharma turns ex-dividend July 7 for a Rs 5 final dividend; check record date, AGM and other details.

July 6, 2026 16:12 IST

Sun Pharma Q4FY26 brokerage outlook and target price analysis

Sun Pharma Q4FY26: Why 3 Brokerages recommend a ‘Buy’ but one is stepping back

Sun Pharma’s Q4FY26 numbers missed on margins but not on confidence. Three brokerages stayed bullish as specialty medicines, India growth…

May 25, 2026 11:30 IST

Sun Pharma-Organon $11.75 billion deal – 5 ‘must know’ details – Stock surges 7%

From nearly doubling EBITDA to becoming a top player in biosimilars and women’s health, here are five key takeaways investors…

April 27, 2026 11:11 IST

Sun Pharma surges 7% – To acquire Organon in $11.75 billion all-cash deal; expects cash flow to nearly double

Sun Pharmaceutical to acquire Organon in an $11.75 billion all-cash deal, marking its entry into biosimilars and strengthening its global…

Updated: April 27, 2026 10:18 IST

The list recognises next-generation leaders under the age of 50 who run family-owned, listed businesses, and ranks them by how many times over they grew their company's market capitalisation between March 2020 and March 2026.

The Rs 26 lakh crore surge: Meet India’s next-gen wealth creators: Jupiter Wagons, Adani Ports, Sun Pharma among top 10

According to the report, Vikash Lohia of Jupiter Wagons leads with a 152.8x growth multiple. Behind him, in a tie…

Updated: April 22, 2026 19:01 IST

A technical stock market dashboard showing the FII long-short ratio at 16.8, with Sun Pharma and Tata Steel charts highlighting "Doji" and "Reversal" candlestick patterns near key support levels.

Monday Watchlist: Vedanta, Tata Steel, and 7 other stocks to watch – Small-caps show strength

Monday watchlist, April 05: Track Vedanta, Tata Steel, and top small-caps as technical trends signal possible short-term reversals—review market moves…

April 6, 2026 05:30 IST

sun pharma us tariff exposure jefferies report

US Tariff concerns: Jefferies explains why Sun Pharma could face the biggest hit—But not the worst outcome

Sun Pharma may be the most exposed to US tariffs but a global buffer could quietly limit the real damage.

April 3, 2026 07:55 IST

₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030

A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40–50% post patent…

March 31, 2026 05:27 IST

A financial chart showing the India VIX surging to 27, its highest since the Russia-Ukraine war, alongside a list of oversold stocks like HDFC Bank and ICICI Bank poised for a relief rally.

Monday Watchlist: Sun Pharma, HDFC Bank, ICICI, and 7 stocks to watch – VIX hits 2-year high

Monday watchlist, March 30: Track Sun Pharma, HDFC Bank and ICICI as market volatility surges; review key stock setups and…

March 30, 2026 05:30 IST

The brokerage believes semaglutide could become a meaningful growth driver for India’s pharma sector, but as more players enter and pricing pressure builds, execution, pricing strategy and distribution strength will determine long-term winners.

Alkem, Zydus Life: Nomura’s top picks to bet on Rs 12,000 crore generic Semaglutide opportunity

Nomura has a ‘Buy’ rating on Zydus Lifesciences, with the stock at Rs 891 and a target price of Rs…

March 23, 2026 14:55 IST

semaglutide india pharma stocks ozempic patent expiry

Sun Pharma to Cipla: 7 pharma stocks gear up for Rs 5,000 cr semaglutide opportunity after patent expiry

Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7…

March 20, 2026 17:58 IST

Divis Labs GLP drug manufacturing opportunity

Nuvama’s top 5 pharma sector ‘Buy’ with up to 43% upside potential

Brokerage major Nuvama turns bullish on five pharma and healthcare stocks, citing semaglutide launches, CGHS rate revisions, capacity expansion and…

Updated: February 11, 2026 16:24 IST

stocks making biggest moves midday Sensex Nifty

Stocks making biggest moves midday: IndiGo, Eternal, Tanla, United Spirits, Ujjivan Small Finance Bank and more

Markets stay volatile as select midcaps like Tanla Platforms and Bandhan Bank surge even as IndiGo and Eternal slip post-Q3…

Updated: January 23, 2026 15:08 IST

Sun Pharma Lupin Torrent Intas GLP-1 obesity drugs India 2026

Rs 10,000-crore opportunity: Sun Pharma, Lupin, Torrent to lead 2026 weight-loss market as Ozempic patent expires

A revolution in India’s weight-loss market is coming. As Semaglutide’s patent ends in 2026, Sun Pharma, Lupin, Torrent, and Intas…

December 31, 2025 17:06 IST

Sun Pharma recalls 17,000 units of antifungal shampoo in US over manufacturing issues

Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to manufacturing-related quality…

December 25, 2025 17:05 IST

Sun Pharmaceutical

Related News

Trending Topics